Primary sclerosing cholangitis

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 5, 2010, Pages 655-666

  Karlsen, Tom H ^a   Schrumpf, Erik ^a   Boberg, Kirsten Muri ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Co morbidities; Disease progression; Genetic predisposition; Primary sclerosing cholangitis; Treatment

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADENOCARCINOMA; ADJUVANT THERAPY; AUTOIMMUNE HEPATITIS; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER DIAGNOSIS; CLINICAL FEATURE; COLORECTAL CANCER; COMORBIDITY; DISEASE COURSE; ENDOSCOPY; ENTERITIS; ENVIRONMENTAL FACTOR; FOLLOW UP; GENETIC RISK; GENETIC SUSCEPTIBILITY; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; NONHUMAN; PHENOTYPE; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; REVIEW;

EID: 77958096734     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.07.005     Document Type: Article

References (100)

1. R.H. Wiesner, and N.F. LaRusso Clinicopathologic features of the syndrome of primary sclerosing cholangitis Gastroenterology 79 1980 200 206
2. J. Ludwig, R.L. MacCarty, N.F. LaRusso, R.A. Krom, and R.H. Wiesner Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis Hepatology 6 1986 560 568
3. D.J. Brandt, R.L. MacCarty, J.W. Charboneau, N.F. LaRusso, R.H. Wiesner, and J. Ludwig Gallbladder disease in patients with primary sclerosing cholangitis AJR Am J Roentgenol 150 1988 571 574
4. K.M. Boberg, E. Aadland, J. Jahnsen, N. Raknerud, M. Stiris, and H. Bell Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population Scand J Gastroenterol 33 1998 99 103
5. A. Escorsell, A. Pares, J. Rodes, J.A. Solis-Herruzo, M. Miras, and E. de la Morena Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver J Hepatol 21 1994 787 791
6. T.L. Ang, K.M. Fock, T.M. Ng, E.K. Teo, T.S. Chua, and J.Y. Tan Clinical profile of primary sclerosing cholangitis in Singapore J Gastroenterol Hepatol 17 2002 908 913
7. U. Broome, R. Olsson, and L. Loof Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 1996 610 615
8. E. Aadland, E. Schrumpf, and O. Fausa Primary sclerosing cholangitis: a long-term follow-up study Scand J Gastroenterol 22 1987 655 664 (Pubitemid 17134654)
9. R.H. Wiesner Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease Best Pract Res Clin Gastroenterol 15 2001 667 680
10. K.M. Boberg, E. Schrumpf, and O. Fausa Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis Scand J Gastroenterol 29 1994 744 752
11. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
12. O. Fausa, E. Schrumpf, and K. Elgjo Relationship of inflammatory bowel disease and primary sclerosing cholangitis Semin Liver Dis 11 1991 31 39
13. E.V. Loftus Jr., G.C. Harewood, and C.G. Loftus PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 2005 91 96
14. M. Joo, P. Abreu-e-Lima, and F. Farraye Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study Am J Surg Pathol 33 2009 854 862
15. R.M. Soetikno, O.S. Lin, P.A. Heidenreich, H.S. Young, and M.O. Blackstone Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis Gastrointest Endosc 56 2002 48 54
16. J.E. Hay, R.H. Wiesner, R.G. Shorter, N.F. LaRusso, and W.P. Baldus Primary sclerosing cholangitis and celiac disease. A novel association Ann Intern Med 109 1988 713 717
17. S. Saarinen, O. Olerup, and U. Broome Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis Am J Gastroenterol 95 2000 3195 3199
18. F.D. Mendes, C. Levy, F.B. Enders, E.V. Loftus Jr., P. Angulo, and K.D. Lindor Abnormal hepatic biochemistries in patients with inflammatory bowel disease Am J Gastroenterol 102 2007 344 350
19. R. Chapman, J. Fevery, and A. Kalloo Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2010 660 678
20. EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 2009 237 267
21. J.J. Tischendorf, H. Hecker, M. Kruger, M.P. Manns, and P.N. Meier Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study Am J Gastroenterol 102 2007 107 114
22. E. Schrumpf, K. Elgjo, O. Fausa, E. Gjone, F. Kolmannskog, and S. Ritland Sclerosing cholangitis in ulcerative colitis Scand J Gastroenterol 15 1980 689 697
23. R.W. Chapman, B.A. Arborgh, and J.M. Rhodes Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology Gut 21 1980 870 877
24. T.R. Riley, R.E. Schoen, R.G. Lee, and J. Rakela A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease Am J Gastroenterol 92 1997 279 282
25. R. Abdalian, and E.J. Heathcote Sclerosing cholangitis: a focus on secondary causes Hepatology 44 2006 1063 1074
26. E.V. Sandborn, W.J. Loftus Jr., and W.J. Tremaine Primary sclerosing cholangitis is associated with nonsmoking: a case-control study Gastroenterology 110 1996 1496 1502
27. T.H. Karlsen, E. Melum, and A. Franke The utility of genome-wide association studies in hepatology Hepatology 51 2010 1833 1842
28. A. Bergquist, S.M. Montgomery, and S. Bahmanyar Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis Clin Gastroenterol Hepatol 6 2008 939 943
29. T.H. Karlsen, A. Franke, and E. Melum Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 2010 1102 1111
30. T.H. Karlsen, K.M. Boberg, and M. Vatn Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis Genes Immun 8 2007 275 278
31. T.H. Karlsen, J. Hampe, and K. Wiencke Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis Am J Gastroenterol 102 2006 115 121
32. T.H. Karlsen, K.M. Boberg, and M. Olsson Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis J Hepatol 46 2007 899 906
33. J.R. Hov, A. Lleo, and C. Selmi Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C J Hepatol 52 2010 712 717
34. P.M.H.C. Parham class I molecules and KIRs in human history, health and survival Nat Rev Immunol 5 2005 201 214
35. T.H. Karlsen, E. Schrumpf, and K.M. Boberg Update on primary sclerosing cholangitis Dig Liver Dis 42 2010 390 400
36. V. Keitel, K. Cupisti, C. Ullmer, W.T. Knoefel, R. Kubitz, and D. Haussinger The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders Hepatology 50 2009 861 870
37. V. Keitel, M. Donner, S. Winandy, R. Kubitz, and D. Haussinger Expression and function of the bile acid receptor TGR5 in Kupffer cells Biochem Biophys Res Commun 372 2008 78 84
38. C. Colombo Liver disease in cystic fibrosis Curr Opin Pulm Med 13 2007 529 536
39. P.G. Blanco, M.M. Zaman, and O. Junaidi Induction of colitis in cftr-/- mice results in bile duct injury Am J Physiol Gastrointest Liver Physiol 287 2004 G491 G496
40. A. Franke, T. Balschun, and T.H. Karlsen Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility Nat Genet 40 2008 1319 1323
41. J. Ludwig Surgical pathology of the syndrome of primary sclerosing cholangitis Am J Surg Pathol 13 Suppl. 1 1989 43 49
42. K.W. Burak, P. Angulo, and K.D. Lindor Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 98 2003 1155 1158
43. W.R. Kim, T.M. Therneau, and R.H. Wiesner A revised natural history model for primary sclerosing cholangitis Mayo Clin Proc 75 2000 688 694
44. K.M. Boberg, G. Rocca, and T. Egeland Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis Hepatology 35 2002 652 657
45. E.R. Dickson, P.A. Murtaugh, and R.H. Wiesner Primary sclerosing cholangitis: refinement and validation of survival models Gastroenterology 103 1992 1893 1901
46. E. Bjornsson, J. Lindqvist-Ottosson, M. Asztely, and R. Olsson Dominant strictures in patients with primary sclerosing cholangitis Am J Gastroenterol 99 2004 502 508 (Pubitemid 38524130)
47. R.A. Kozarek Endoscopic therapy in primary sclerosing cholangitis. Dominant strictures may not matter: does that mean that endotherapy does not work? Am J Gastroenterol 99 2004 509 510
48. E. Bjornsson, and R. Olsson Dominant strictures in patients with primary sclerosing cholangitis-revisited Am J Gastroenterol 99 2004 2281 (Pubitemid 39524722)
49. R.G. Olsson, and M.S. Asztely Prognostic value of cholangiography in primary sclerosing cholangitis Eur J Gastroenterol Hepatol 7 1995 251 254
50. D.A. Craig, R.L. MacCarty, R.H. Wiesner, P.M. Grambsch, and N.F. LaRusso Primary sclerosing cholangitis: value of cholangiography in determining the prognosis AJR Am J Roentgenol 157 1991 959 964
51. C.Y. Ponsioen, S.M. Vrouenraets, and W. Prawirodirdjo Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population Gut 51 2002 562 566
52. G. Rudolph, D. Gotthardt, P. Kloters-Plachky, H. Kulaksiz, D. Rost, and A. Stiehl Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis J Hepatol 51 2009 149 155
53. A. Stiehl, G. Rudolph, P. Kloters-Plachky, P. Sauer, and S. Walker Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment J Hepatol 36 2002 151 156
54. E. Melum, K.M. Boberg, and A. Franke Variation in the MDR3 gene influences disease progression in PSC patients and disease susceptibility in epistatic interaction with polymorphism in OST-alpha gene Hepatology 46 2007 265A
55. T.H. Karlsen, B.A. Lie, and K. Frey Froslie Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis Gastroenterology 131 2006 781 787
56. R.H. Palmer Bile acids, liver injury, and liver disease Arch Intern Med 130 1972 606 617
57. D.J. Parks, S.G. Blanchard, and R.K. Bledsoe Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
58. G.L. Guo, G. Lambert, and M. Negishi Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity J Biol Chem 278 2003 45062 45071
59. W. Xie, A. Radominska-Pandya, and Y. Shi An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids Proc Natl Acad Sci U S A 98 2001 3375 3380
60. S. Khurana, and P. Singh Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials Liver Int 26 2006 943 948
61. M. Ziol, V. Barbu, and O. Rosmorduc ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults Gastroenterology 135 2008 131 141
62. D. Gotthardt, H. Runz, and V. Keitel A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults Hepatology 48 2008 1157 1166
63. K.M. Boberg, A. Bergquist, and S. Mitchell Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand J Gastroenterol 37 2002 1205 1211
64. T.H. Karlsen, E. Schrumpf, and K.M. Boberg Gallbladder polyps in primary sclerosing cholangitis: not so benign Curr Opin Gastroenterol 24 2008 395 399
65. A. Bergquist, A. Ekbom, and R. Olsson Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 2002 321 327
66. K.A. Fleming, K.M. Boberg, H. Glaumann, A. Bergquist, D. Smith, and O.P. Clausen Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis J Hepatol 34 2001 360 365
67. S. Kobayashi, N.W. Werneburg, S.F. Bronk, S.H. Kaufmann, and G.J. Gores Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells Gastroenterology 128 2005 2054 2065
68. D. Komichi, S. Tazuma, T. Nishioka, H. Hyogo, and K. Chayama Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage Free Radic Biol Med 39 2005 1418 1427
69. E. Melum, T.H. Karlsen, and E. Schrumpf Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms Hepatology 47 2008 90 96 (Pubitemid 351171045)
70. K.D. Lindor Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group N Engl J Med 336 1997 691 695
71. R. Olsson, K.M. Boberg, and O.S. de Muckadell High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study Gastroenterology 129 2005 1464 1472
72. K.D. Lindor, K.V. Kowdley, and V.A. Luketic High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis Hepatology 50 2009 808 814
73. K.M. Boberg, T. Egeland, and E. Schrumpf Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients Scand J Gastroenterol 38 2003 991 995
74. S. Luth, S. Kanzler, and C. Frenzel Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome J Clin Gastroenterol 43 2009 75 80
75. T.H. Florin, N. Pandeya, and G.L. Radford-Smith Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases Gut 53 2004 973 979
76. A.H. Kartheuser, R.R. Dozois, N.F. LaRusso, R.H. Wiesner, D.M. Ilstrup, and C.D. Schleck Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy Mayo Clin Proc 71 1996 748 756
77. C. Penna, R. Dozois, and W. Tremaine Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis Gut 38 1996 234 239 (Pubitemid 26046819)
78. K. Freeman, Z. Shao, F.H. Remzi, R. Lopez, V.W. Fazio, and B. Shen Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis Clin Gastroenterol Hepatol 6 2008 62 68
79. G.J. Gores, D.M. Nagorney, and C.B. Rosen Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 47 2007 455 459
80. E.V. Loftus Jr., H.I. Aguilar, and W.J. Sandborn Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation Hepatology 27 1998 685 690
81. K.M. Boberg, P. Jebsen, O.P. Clausen, A. Foss, L. Aabakken, and E. Schrumpf Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis J Hepatol 45 2006 568 574
82. N. Chalasani, A. Baluyut, and A. Ismail Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study Hepatology 31 2000 7 11
83. B. Brandsaeter, H. Isoniemi, and U. Broome Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy J Hepatol 40 2004 815 822
84. K. Bjoro, B. Brandsaeter, A. Foss, and E. Schrumpf Liver transplantation in primary sclerosing cholangitis Semin Liver Dis 26 2006 69 79
85. T. Uemura, T. Ikegami, and E.Q. Sanchez Late acute rejection after liver transplantation impacts patient survival Clin Transplant 22 2008 316 323
86. I.W. Graziadei, R.H. Wiesner, and P.J. Marotta Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatology 30 1999 1121 1127
87. Neuberger J. Incidence timing, and risk factors for acute and chronic rejection Liver Transpl Surg 5 1999 S30 S36
88. R. Hanvesakul, N. Spencer, and M. Cook Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation Am J Transplant 8 2008 1931 1941
89. A. Bishara, C. Brautbar, G. Zamir, A. Eid, and R. Safadi Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome Hum Immunol 66 2005 1099 1105
90. I.W. Graziadei, R.H. Wiesner, and K.P. Batts Recurrence of primary sclerosing cholangitis following liver transplantation Hepatology 29 1999 1050 1056
91. B. Brandsaeter, E. Schrumpf, and O. Bentdal Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors Liver Transpl 11 2005 1361 1369
92. J. Alexander, J.D. Lord, M.M. Yeh, C. Cuevas, R. Bakthavatsalam, and K.V. Kowdley Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 14 2008 245 251
93. M. Kugelmas, P. Spiegelman, and M.J. Osgood Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 9 2003 727 732
94. A. Vera, S. Moledina, and B. Gunson Risk factors for recurrence of primary sclerosing cholangitis of liver allograft Lancet 360 2002 1943 1944
95. E. Alabraba, P. Nightingale, and B. Gunson A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts Liver Transpl 15 2009 330 340
96. D.H. Adams, and B. Eksteen Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease Nat Rev Immunol 6 2006 244 251
97. G.V. Papatheodoridis, M. Hamilton, P.K. Mistry, B. Davidson, K. Rolles, and A.K. Burroughs Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis Gut 43 1998 639 644
98. I. Dvorchik, M. Subotin, and A.J. Demetris Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis Hepatology 35 2002 380 384
99. R.C. Verdonk, G. Dijkstra, and E.B. Haagsma Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease Am J Transplant 6 2006 1422 1429
100. E.B. Haagsma, A.P. Van Den Berg, J.H. Kleibeuker, M.J. Slooff, and G. Dijkstra Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens Aliment Pharmacol Ther 18 2003 33 44